Since 1992, Doylestown Hospital's membership
in the University of Pennsylvania (Penn) Cancer
Network has continued to enhance the scope,
strength and prestige of its cancer program and its
level of patient care, clinical research and education.
"We partner with institutions, such as
Doylestown Hospital, that already have an excellent
reputation in their community and then work
with them on the development or expansion of their
cancer program," says Jeanne M. Rogers, RN, MEd,
Associate Executive Director of the Abramson
Cancer Center of the University of Pennsylvania
and Administrative Director of the University of
Pennsylvania Cancer Network.
"We complement the excellent programs and
services offered at Doylestown Hospital with highly
specialized clinical services, such as bone marrow
transplantation and Phase I clinical research studies,"
Ms. Rogers says. "Our goal is to provide a seamless
system of care for patients and their families."
The Abramson Cancer Center of the
University of Pennsylvania is one of the nation's
leading cancer centers. It is among an elite group
of cancer centers in the county designated by the
National Cancer Institute (NCI) as a Comprehensive
Cancer Center.
Penn established the Cancer Network in 1991 to
bring the latest research, preventive, diagnostic and
treatment approaches to the community. It is one of
the largest networks of its kind in the country, with
22 members in eastern Pennsylvania and central and
southern New Jersey.
"Doylestown Hospital has an excellent cancer
program, and we are proud to have them as a
member of the University of Pennsylvania Cancer
Network," Ms. Rogers concludes.
